X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (474) 474
Publication (34) 34
Book Chapter (26) 26
Book Review (5) 5
Reference (5) 5
Conference Proceeding (2) 2
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (279) 279
rheumatology (195) 195
child (186) 186
index medicus (180) 180
female (177) 177
male (171) 171
adolescent (137) 137
pediatrics (135) 135
children (110) 110
child, preschool (106) 106
familial mediterranean fever (106) 106
mutation (58) 58
medicine & public health (51) 51
adult (49) 49
disease (49) 49
diagnosis (48) 48
vasculitis (47) 47
urology & nephrology (46) 46
familial mediterranean fever - genetics (43) 43
treatment outcome (41) 41
infant (39) 39
classification (38) 38
familial mediterranean fever - diagnosis (37) 37
inflammation (37) 37
care and treatment (35) 35
criteria (35) 35
genetic aspects (35) 35
arthritis (34) 34
fever (34) 34
mutations (34) 34
fmf (33) 33
risk factors (33) 33
severity of illness index (33) 33
patients (32) 32
amyloidosis (31) 31
retrospective studies (31) 31
abridged index medicus (29) 29
familial mediterranean fever - drug therapy (29) 29
turkey (29) 29
colchicine (28) 28
immunology and allergy (28) 28
familial mediterranean fever - complications (27) 27
immunology (26) 26
immunosuppressive agents - therapeutic use (26) 26
pyrin (26) 26
childhood (25) 25
research (25) 25
juvenile idiopathic arthritis (24) 24
young adult (24) 24
gene (23) 23
henoch-schonlein purpura (23) 23
polyarteritis-nodosa (23) 23
systemic lupus erythematosus (23) 23
analysis (22) 22
colchicine - therapeutic use (22) 22
rheumatoid-arthritis (22) 22
treatment (21) 21
diagnosis, differential (20) 20
prognosis (20) 20
age of onset (19) 19
middle aged (19) 19
nephrology (19) 19
poster presentation (19) 19
biopsy (18) 18
phenotype (18) 18
diseases (17) 17
epidemiology (17) 17
management (17) 17
pediatrics, perinatology, and child health (17) 17
polyarteritis nodosa (16) 16
prevalence (16) 16
therapy (16) 16
antirheumatic agents - therapeutic use (15) 15
association (15) 15
cytoskeletal proteins - genetics (15) 15
genetic predisposition to disease (15) 15
internal medicine (15) 15
population (15) 15
anakinra (14) 14
autoinflammatory diseases (14) 14
case-control studies (14) 14
cytokines (14) 14
follow-up studies (14) 14
genotype (14) 14
health aspects (14) 14
international cooperation (14) 14
journal article (14) 14
rheumatology 1990 criteria (14) 14
studies (14) 14
takayasu arteritis (14) 14
arthritis, juvenile - drug therapy (13) 13
diseases of the musculoskeletal system (13) 13
drug therapy, combination (13) 13
frequency (13) 13
glucocorticoids - therapeutic use (13) 13
hereditary autoinflammatory diseases - diagnosis (13) 13
lupus erythematosus, systemic - complications (13) 13
medicine (13) 13
pedigree (13) 13
reproducibility of results (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2009, Volume 106, Issue 45, pp. 19096 - 19101
Journal Article
Seminars in arthritis and rheumatism, ISSN 0049-0172, 08/2019
Recently a new set of criteria proposed for the classification of auto inflammatory recurrent fevers including familial Mediterranean Fever (FMF). We aimed to... 
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. 1965 - 1973
Lupus nephritis (LN) occurs in 50%–60% of patients with childhood-onset systemic lupus erythematosus (cSLE), leading to significant morbidity. Timely... 
disease activity | treatment | lupus nephritis | systemic lupus erythematosus | corticosteroids | ERYTHEMATOSUS NEPHRITIS | INTRAVENOUS CYCLOPHOSPHAMIDE THERAPY | SINGLE-CENTER EXPERIENCE | IMMUNOSUPPRESSIVE THERAPY | PERSISTENT PROTEINURIA | INDUCTION THERAPY | TASK-FORCE | PROGNOSTIC-SIGNIFICANCE | IRANIAN CHILDREN | RHEUMATOLOGY | MYCOPHENOLATE-MOFETIL | Azathioprine - therapeutic use | Europe | Humans | Immunosuppressive Agents - therapeutic use | Lupus Nephritis - drug therapy | Treatment Outcome | Adrenal Cortex Hormones - therapeutic use | Cyclophosphamide - therapeutic use | Evidence-Based Medicine - standards | Mycophenolic Acid - therapeutic use | Age of Onset | Remission Induction - methods | Disease Management | Child | Lupus Nephritis - diagnosis | Antirheumatic Agents - therapeutic use | Practice Guidelines as Topic | Prevention | Care and treatment | Antirheumatic agents | Kidney failure | Systemic lupus erythematosus | Dosage and administration | Diagnosis | Corticoids | Adolescence | Pediatrics | Nephritis | Mycophenolic acid | Intravenous administration | Experts | Arthritis | Lupus nephritis | Medical diagnosis | Literature reviews | Rheumatism | Teenagers | Children | Lupus | Urine | Kidneys | Rheumatic diseases | Rheumatology | Prednisone | Patients | Morbidity | Studies | Cyclophosphamide | Biopsy | Kidney diseases | Mycophenolate mofetil | Azathioprine | Proteinuria | Kidney transplantation | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2016, Volume 113, Issue 36, pp. 10127 - 10132
Systemic autoinflammatory diseases are caused by mutations in genes that function in innate immunity. Here, we report an autoinflammatory disease caused by... 
Autoinflammatory disease | Cytokines | Nf-κb pathway | Linear deubiquitinase | OTULIN | ACTIVATION | AMYLOPECTINOSIS | NF-kappa B pathway | UBIQUITIN | MULTIDISCIPLINARY SCIENCES | linear deubiquitinase | ASSEMBLY COMPLEX | CELL-DEATH | HOIP | SHARPIN | autoinflammatory disease | INFLAMMATION | LUBAC DEFICIENCY | cytokines | IMMUNODEFICIENCY | Fibroblasts - enzymology | Humans | NF-kappa B - immunology | Child, Preschool | Male | Fever - physiopathology | Leukocytes, Mononuclear - immunology | HEK293 Cells | Female | Child | Cytokines - genetics | Failure to Thrive - physiopathology | Hereditary Autoinflammatory Diseases - pathology | Cytokines - immunology | Dermatitis - physiopathology | Signal Transduction | Hereditary Autoinflammatory Diseases - enzymology | Gene Expression Regulation | Ubiquitin - genetics | Endopeptidases - deficiency | Hereditary Autoinflammatory Diseases - diagnosis | Fibroblasts - pathology | Endopeptidases - immunology | Leukocytes, Mononuclear - pathology | Endopeptidases - genetics | NF-kappa B - genetics | Pedigree | Age of Onset | Alleles | Fibroblasts - immunology | Leukocytes, Mononuclear - enzymology | Panniculitis - physiopathology | Consanguinity | Mutation | Ubiquitin - immunology | Hereditary Autoinflammatory Diseases - genetics | Allelomorphism | Genetic aspects | Gene mutations | Autoimmune diseases | Health aspects | Biological Sciences | NF-κB pathway
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 03/2017, Volume 8, p. 253
Journal Article
by Ombrello, Michael J and Arthur, Victoria L and Remmers, Elaine F and Hinks, Anne and Tachmazidou, Ioanna and Grom, Alexei A and Foell, Dirk and Martini, Alberto and Gattorno, Marco and Özen, Seza and Prahalad, Sampath and Zeft, Andrew S and Bohnsack, John F and Ilowite, Norman T and Mellins, Elizabeth D and Russo, Ricardo and Len, Claudio and Hilario, Maria Odete E and Oliveira, Sheila and Yeung, Rae S M and Rosenberg, Alan M and Wedderburn, Lucy R and Anton, Jordi and Haas, Johannes-Peter and Rosen-Wolff, Angela and Minden, Kirsten and Tenbrock, Klaus and Demirkaya, Erkan and Cobb, Joanna and Baskin, Elizabeth and Signa, Sara and Shuldiner, Emily and Duerr, Richard H and Achkar, Jean-Paul and Kamboh, M Ilyas and Kaufman, Kenneth M and Kottyan, Leah C and Pinto, Dalila and Scherer, Stephen W and Alarcón-Riquelme, Marta E and Docampo, Elisa and Estivill, Xavier and Gül, Ahmet and Langefeld, Carl D and Thompson, Susan and Zeggini, Eleftheria and Kastner, Daniel L and Woo, Patricia and Thomson, Wendy and Childhood Arthrit Prospective Stud and Randomized Placebo Phase Study Ril and Biologically Based Outcome Predict and Inception Cohort Newly Diagnosed P and Sparks-Childhood Arthrit Response and British Soc Pediat Adolescent Rheu and British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis (ICON-JIA) Study Group, Childhood Arthritis Prospective Study (CAPS) Group, Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators, Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group, Biologically Based Outcome Predictors in JIA (BBOP) Group
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2017, Volume 76, Issue 5, pp. 906 - 913
Journal Article
Journal Article
by Ombrello, Michael J and Remmers, Elaine F and Tachmazidou, Ioanna and Grom, Alexei and Foell, Dirk and Haas, Johannes-Peter and Martini, Alberto and Gattorno, Marco and Özen, Seza and Prahalad, Sampath and Zeft, Anew S and Bohnsack, John F and Mellins, Elizabeth D and Ilowite, Norman T and Russo, Ricardo and Len, Claudio and Hilario, Maria Odete E and Oliveira, Sheila and Yeung, Rae S M and Rosenberg, Alan and Wedderburn, Lucy R and Anton, Jordi and Schwarz, Tobias and Hinks, Anne and Bilginer, Yelda and Park, Jane and Cobb, Joanna and Satorius, Colleen L and Han, Buhm and Baskin, Elizabeth and Signa, Sara and Duerr, Richard H and Achkar, J P and Kamboh, M Ilyas and Kaufman, Kenneth M and Kottyan, Leah C and Pinto, Dalila and Scherer, Stephen W and Alarcón-Riquelme, Marta E and Docampo, Elisa and Estivill, Xavier and Gül, Ahmet and de Bakker, Paul I W and Raychaudhuri, Soumya and Langefeld, Carl D and Thompson, Susan and Zeggini, Eleftheria and Thomson, Wendy and Kastner, Daniel L and Woo, Patricia and Int Childhood Arthritis Genetics and BSPAR Study Grp and BBOP Grp and Randomized Placebo Phase Study and CHARMS Grp and Childhood Arthritis Prospective Study (CAPS) Group and International Childhood Arthritis Genetics (INCHARGE) Consortium and British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group and Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators and Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group and Biologically Based Outcome Predictors in JIA (BBOP) Group and the International Childhood Arthritis Genetics (INCHARGE) Consortium
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2015, Volume 112, Issue 52, pp. 15970 - 15975
Journal Article
Best Practice & Research Clinical Rheumatology, ISSN 1521-6942, 04/2018, Volume 32, Issue 2, pp. 254 - 260
Autoinflammatory diseases (AIDs) are diseases of the innate immune system, with clinical and laboratory evidence of attacks of inflammation. The more common... 
Autoinflammatory diseases | Epidemiology | Familial Mediterranean fever | CRITERIA | DIAGNOSIS | FREQUENCY | VALIDATION | PREVALENCE | MUTATIONS | RHEUMATOLOGY | DEFINE | SEVERITY | Genetic aspects
Journal Article
Journal of Inflammation Research, ISSN 1178-7031, 03/2016, Volume 9, pp. 13 - 20
Familial Mediterranean fever (FMF) is the most frequent monogenic autoinflammatory disease, and it is characterized by recurrent attacks of fever and... 
Child | Recommendation | Familial meditarranean fever | Familial Mediterranean fever | Genetic aspects | Research | Gene mutations | Risk factors | Genotype & phenotype | Pediatrics | Pathogenesis | Rheumatology | Inflammation | Arthritis | Mutation | Fever
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 03/2018, Volume 187, pp. 158 - 166
Journal Article